Loading…
Saving Access to Compounded Medications for Special Needs Patients Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,548 other S bills in the 114th — cohort avg 43d
Saving Access to Compounded Medications for Special Needs Patients Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow drugs to be compounded (manufactured at a small scale) and distributed to practitioners for treatment of, or administration to, patients of that practitioner. Currently, drugs may be compounded only for identified individual patients. (Compounded drugs do not need to meet certain requirements for drugs regarding manufacturing, labeling, or FDA approval.) Compounded drugs must comply with United States Pharmacopeia standards. A memorandum of understanding (MOU) between the FDA and a state regarding compounded drugs no longer must address interstate distribution of inordinate amounts of compounded drugs. Such an MOU must not create an unfunded mandate on a state. (Compounders in states that do not have an MOU with the FDA may not distribute more than 5% of their orders out of state.)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S. 1406, Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S. 1406, Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S. 1406, Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Arts/Entertainment
HR 1518 S1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Animals
HR 1518 S 1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Arts/Entertainment
HR 1518 S1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Animals
HR 1518 S 1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · fourth_quarter · Health Issues
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · fourth_quarter · Pharmacy
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees;
Client expense: $245,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $18,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · third_quarter · Health Issues
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · third_quarter · Pharmacy
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees; H.R. 5951/S. 3308 - Improving Transparency and Accuracy in Medicare Part D Spending Act
Client expense: $335,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $18,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Arts/Entertainment
HR 1518 S1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Animals
HR 1518 S 1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Arts/Entertainment
HR 1518 S1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · first_quarter · Animals
HR 1518 S 1406
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Lobby members of House to write to FDA regarding the agencys draft guidance document on office-use compounding Support S. 2615, the Increasing Competition in Pharmaceuticals Act Lobby members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, and to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby members of House and Senate to send letters of support to FDA regarding the agencys proposed rule to restrict indoor tanning for youth under 18. Lobby Congress on issues related to telemedicine. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act). Oppose S.2175, Department of Veterans Affairs Provider Equity Act. Advocate for increased price transparency for drugs and tools to help lower costs. Advocate for Ensuring Childrens Access to Specialty Care Act (H.R. 1859/S. 2782). Advocate regarding proposed indoor tanning regulations and provisions regarding compounded pharmaceuticals under the Senate and House Agriculture Appropriations bills (S.2956/H.R.5054, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017).
Client expense: $400,000 · Firm income: Not reported
2016 · second_quarter · Pharmacy
H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; S. 1406 - Saving Access to Compounding Medications for Special Needs Patients Act; Issues related to FDA implementation of The Drug Quality and Security Act related to compounding; Issues Related to Direct and Indirect Renumeration (DIR) Fees
Client expense: $390,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Personnel Management (OPM), SENATE
2016 · second_quarter · Health Issues
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · second_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills). Pharmacy inspection issues and concerns (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $11,250
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. S.1406-Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $18,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
Client expense: Not reported · Firm income: Not reported
2016 · second_quarter · Medical/Disease Research/Clinical Labs
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
Client expense: Not reported · Firm income: Not reported
2016 · second_quarter · Law Enforcement/Crime/Criminal Justice
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
Client expense: Not reported · Firm income: Not reported
2016 · second_quarter · Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
Client expense: Not reported · Firm income: Not reported
2016 · second_quarter · Budget/Appropriations
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. Appropriations to fund the FDA implementation of compounding pharmacy regulations. Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. Current legislation including, but not limited to the H.R. 5054, S. 2956 and S.1406 (to be updated on subsequent reports).
Client expense: Not reported · Firm income: Not reported
2016 · first_quarter · Health Issues
Issues related to health care as they impact compounding pharmacists (no specific bills). S.1406 - Saving Access to Compounded Medications for Special Needs Patients Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · first_quarter · Pharmacy
Legislation related to the implementation of the Food, Drug, Cosmetic Act related to compounding, HR 3204. Issues related to the introduction of the Saving Access to Compounded Medications for Special Needs Patients Act, S. 1406. Issues related to reimbursement of compounded medications and recommended changes to the Social Security Act; drug pricing (no specific bills).
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · first_quarter · Health Issues
Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Support S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act. Support S. 2615, the Increasing Competition in Pharmaceuticals Act Lobby members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Lobby members of House and Senate to send letters of support to FDA regarding the agencys proposed rule to restrict indoor tanning for youth under 18. Advocate members of Congress for oversight of implementation of Sunscreen Innovation Act. Lobby Congress on issues related to telemedicine. Support legislation to establish a federal standard for the provision of telemedicine (H.R. 691, the Telehealth Modernization Act). Support S.2175, Department of Veterans Affairs Provider Equity Act. Advocate for increased price transparency for drugs and tools to help lower costs.
Client expense: $444,057 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE